Respiratory Medicine Specialist
33 years experience overall
Apollo Hospitals 21, Greams Lane, Off Greams Road Chennai 600 006 Ph:044-28290200/3333, Chennai
‘Apollo Hospitals Proceedings’, since its inception in planning, design and content,
2003 till closure.
EDUCATION :
·MBBS
Stanley Medical College, Chennai, India – November 1986
?DTRD (Diploma in Tuberculosis and Respiratory Diseases) #
Madras Medical College, Chennai, India – April 1990
# University (State) First-Rank
?MD
Stanley Medical College, Chennai, India – April 1995
Royal College of Physicians and Surgeons of Glasgow, Glasgow, United Kingdom
–June 2007
PROFESSIONAL MEMBERSHIPS
1. PRESIDENT: Indian Medical Association, Apollo Hospitals - Thousand- lights branch, Chennai
2. Indian Association of Bronchology-Life Member.
3. Indian Medical Association-Life Member.
4. Indian Chest Society – Life member. ACCP (American College of Chest Physicians) – USA– Indian Chapter- Life Member. Association of Physicians of India –Life member.
5. Indian Critical Care Society – Life Member.
6. Fellow of Royal College of Physicians & Surgeons of Glasgow, United Kingdom.
7. VICE-PRESIDENT of FIRST ASSOCIATION OF PULMONOLOGISTS OF TAMILNADU- 2016 [APT] Member, Editorial Board, of FIRST Journal of Association of Pulmonologists of Tamilnadu [JAPI] 2016 Founder Member of Organizing Committee: FIRST TAPPCON Conference -Tamilnadu and Pondicherry Pulmonology Conference-2015 & 2016
8. Member: former-The Global Advisory Board of: The Disease Management Association of India (DMAI)
Member: former-Institutional Ethical Committee -The Tamilnadu Dr. M.G.R Medical University, Chennai, India.
RESEARCH AND PUBLICATIONS
Many in National & International Journals & Peer Reviewer for them.
Principle Investigator, of Phase IV, Open-label, non-comparative, multicentric, trial, titled ‘Use of Meropenem in the treatment of Moderate and Severe Infections’ in 2003.
Investigator (Unblinded Physician) in, global, multicenter, double-blind, comparative, randomized, Phase III trial, to evaluate `The efficacy and safety of Micafungin versus Liposomal Amphotericin B in the treatment of Invasive Candidiasis and Candidaemia`, between 2003 to 2004.
Investigator (Unblinded Physician) in Phase III, global, randomized double-blind comparative study of`` Micafungin versus Caspofungin as an antifungal treatment in patients with Invasive Candidiasis and Candidaemia`, in 2005.
Abovementioned trials subjected to US FDA audit
Trained in ICH-GCP (International Conference on Harmonisation Regulations - Good Clinical Practices).
*Centre Principal Investigator, in the Writing Group of the Global Asthma Network Study Group- 2013 till date
Drug Trials -various @ - Apollo Hospitals ,Chennai , India.
obstructive airway diseases in Indian population.”European Respiratory Society,
International Congress, 2015.
ERS- European Respiratory Society --2017
A] Evaluation of Asthma Control using ACQ & comparison with GINA criteria
Amarendra P ,Ilangho RP
B} Risk factors in OSA
Meghna, Ilangho RP
12. R Narasimhan,B Rajagopalan,C Chandrasekhar,R Velraj, Ilangho Rp et al
:Comprehensive Overview and Evidence Based Clinical Approach to Covid- 19 - An Official Consensus Statement Endorsed By Association of
Pulmonologist of Tamilnadu, Journal of Association of Pulmonologist of Tamil Nadu ; 20203(4):1.DOI: 10.4103/WKMP-0215.309207
13. VaseemaThabassum Shaik, Ilangho Rp, K Bhaskaran :Utility of Ariscat (Assess respiratory risk in surgical patients in catalonia) score in predicting postoperative pulmonary complications in patients undergoing
elective/emergency surgery in a tertiary care Hospital in India.Journal of Association of Pulmonologist of Tamil Nadu, 2021; 4(3):94. DOI: 10.4103/japt.japt_38_21
English,Hindi,Tamil,Telugu
male
Apollo Hospitals 21, Greams Lane, Off Greams Road Chennai 600 006 Ph:044-28290200/3333, Chennai, Tamil Nadu - 600006